Formulations of pimavanserin | Patent Number 10646480

US 10646480 B2
Application Number16571554
Publication NumberUS 20200009122 A1
Pendency7 months, 29 days
Filled DateSep 16, 2019
Priority Date-
Publication DateJan 9, 2020
Expiration DateSep 15, 2039
Inventor/ApplicantsStephen Edward Abele
Ravi Tejwani
Emanuel Joseph Vizzotti
ExaminesYOUNG, MICAH PAUL
Art Unit1618
Technology Center1600
Assignments
Acadia Pharmaceuticals Inc.
Current
Acadia Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.